A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2002
12/19/2002	US20020192239 In situ administering; neuralgia
12/19/2002	US20020192232 Methods and compositions for impairing multiplication of HIV-1
12/19/2002	US20020192228 Protein markers for lung cancer and use thereof
12/19/2002	US20020192223 Novel antibody conjugates reactive with human carcinomas
12/19/2002	US20020192222 Receptor specific transepithelial transport of therapeutics
12/19/2002	US20020192220 Compositions and methods relating to colon specific genes and proteins
12/19/2002	US20020192218 Oncoprotein protein kinase
12/19/2002	US20020192217 Methods for regulation of immune responses to conditions involving mediator-induced pathology
12/19/2002	US20020192216 Therapeutic use
12/19/2002	US20020192215 Novel uses of mammalian OX2 protein and related reagents
12/19/2002	US20020192214 Eosinophil eotaxin receptor
12/19/2002	US20020192213 Monoclonal antibodies specific to VEGF receptors and uses thereof
12/19/2002	US20020192208 Novel osteopontin derived chemotactic peptides and methods of use
12/19/2002	US20020192207 Pharmaceutical compositions of fibrinolytic agent
12/19/2002	US20020192206 Methods and compositions for angioproliferative disorder treatment
12/19/2002	US20020192203 Sterol absorption inhibitor compositions
12/19/2002	US20020192202 Probiotic compounds derived from lactobacillus casei strain KE01
12/19/2002	US20020192199 Composition and methods for enhanced tumor cell immunity in vivo
12/19/2002	US20020192195 Use of MHC class II ligands as adjuvant for vaccination and of LAG-3 in cancer treatment
12/19/2002	US20020192193 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192192 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192188 Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft
12/19/2002	US20020192186 Gene therapy for pulmonary edema using adenovirus vectors encoding Na,K-ATPase
12/19/2002	US20020192183 Interferon gamma polypeptide variants
12/19/2002	US20020192164 Methods and compositions for the pulmonary delivery insulin
12/19/2002	US20020192162 Methods for using annexin for detecting cell death in vivo and treating associated conditions
12/19/2002	DE10127712A1 Use of immunoglobulin M for treatment and prevention of systemic lupus erythematosus, administered subcutaneously or intramuscularly
12/19/2002	CA2852202A1 Calcium phosphate delivery vehicles for osteoinductive proteins
12/19/2002	CA2488850A1 Sustained release n-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating cancer
12/19/2002	CA2487039A1 Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases
12/19/2002	CA2487038A1 Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
12/19/2002	CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
12/19/2002	CA2450240A1 Treatment and composition for wound healing
12/19/2002	CA2450113A1 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002	CA2449964A1 Crosslinkable macromers
12/19/2002	CA2449713A1 Calcium phosphate delivery vehicles for osteoinductive proteins
12/19/2002	CA2449687A1 Vascular regeneration therapy
12/19/2002	CA2449649A1 A g-protein coupled receptor and uses therefor
12/19/2002	CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	CA2449591A1 Brain expressed gene and protein associated with bipolar disorder
12/19/2002	CA2449573A1 Bmp binding proteins for use in bone or cartilage regeneration
12/19/2002	CA2449517A1 Tissue-specific endothelial membrane proteins
12/19/2002	CA2449440A1 Structural and cytoskeleton-associated proteins
12/19/2002	CA2449272A1 Intracellular signaling molecules
12/19/2002	CA2449259A1 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
12/19/2002	CA2448432A1 Purification of human serum albumin
12/19/2002	CA2447687A1 Substituted 1-benzazepines and derivatives thereof
12/19/2002	CA2447658A1 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines
12/19/2002	CA2445605A1 Treatment or prophylaxis of insulin-producing cell graft rejection
12/19/2002	CA2418808A1 Human-type anti-blood coagulation factor viii antibody
12/18/2002	EP1267171A1 Cofactor-based screening method for nuclear receptor modulators
12/18/2002	EP1267167A1 Method for identifying HCV entry factors
12/18/2002	EP1266965A2 Recombinant antibodies for human therapy
12/18/2002	EP1266961A1 Kidney repairing factor
12/18/2002	EP1266666A2 Fibrin sealant compositions and method for utilizing same
12/18/2002	EP1266029A1 Diagnosis of a person's risk of developing alcoholism
12/18/2002	EP1266026A1 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase beta/zeta
12/18/2002	EP1266022A2 Cell-specific adenovirus vectors comprising an internal ribosome entry site
12/18/2002	EP1266015A2 Ecdysone receptor-based inducible gene expression system
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002	EP1266013A2 Heparinase iii and uses thereof
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266010A2 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins
12/18/2002	EP1266009A2 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF
12/18/2002	EP1266006A2 Production of recombinant blood clotting factors in human cell lines
12/18/2002	EP1266005A2 Regulation of human lipoxin a4 receptor-like protein
12/18/2002	EP1266004A2 Molecules of the pyrin domain protein family and uses thereof
12/18/2002	EP1266003A2 Kcnb: a potassium channel protein
12/18/2002	EP1266002A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1266000A1 Chordin-like-2 molecules and uses thereof
12/18/2002	EP1265999A2 Human schizophrenia gene
12/18/2002	EP1265998A2 Polypeptides and corresponding polynucleotides for diagnostics and therapeutics
12/18/2002	EP1265997A1 43239, a gpcr-like molecule and uses thereof
12/18/2002	EP1265996A2 Identification of modulators of the interferon gamma signaling pathway and their use in restenosis treatment
12/18/2002	EP1265995A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
12/18/2002	EP1265992A2 Materials and methods relating to the degradation of cdc25a in response to dna damage
12/18/2002	EP1265991A2 Sphingomyelinase enzymes and uses relating thereto
12/18/2002	EP1265989A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis
12/18/2002	EP1265985A1 Pancreatic islet cell growth factors
12/18/2002	EP1265925A2 G protein-coupled receptors
12/18/2002	EP1265924A2 Il-17 receptor like molecules and uses thereof
12/18/2002	EP1265922A2 Agonists and antagonists of the receptor gpr19 and their use in appetite control
12/18/2002	EP1265921A1 Charged compounds comprising a nucleic acid binding moiety and uses therefor
12/18/2002	EP1265920A2 Angiogenesis-associated proteins, and nucleic acids encoding the same
12/18/2002	EP1265918A1 Human immune response proteins
12/18/2002	EP1265917A2 Tlp peptides and dna sequences coding the same
12/18/2002	EP1265916A2 Therapeutic anti-cytomegalovirus compounds
12/18/2002	EP1265915A2 Novel compounds
12/18/2002	EP1265914A2 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/18/2002	EP1265913A1 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto
12/18/2002	EP1265910A2 Nucleic acids, proteins, and antibodies
12/18/2002	EP1265867A1 Novel malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/18/2002	EP1265849A2 Compounds and methods to treat alzheimer's disease
12/18/2002	EP1265639A1 The use of anticoagulant agents in the extracorporeal treatment of blood
12/18/2002	EP1265638A1 Compositions for transdermal and transmucosal administration of therapeutic agents
12/18/2002	EP1265637A2 Compositions and methods for affecting osteogenesis
12/18/2002	EP1265636A2 Improved treatment of neovascularization
12/18/2002	EP1265634A1 Method and composition for treating airway hyperresponsiveness

1 ... 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 ... 3163